Robalo Nunes António, Mairos João, Brilhante Dialina, Marques Filipa, Belo Aurora, Cortez José, Fonseca Cândida
Anemia Working Group Portugal, Av. Columbano Bordalo Pinheiro 75, 1070-061 Lisbon, Portugal.
Immunohemotherapy Service, Armed Forces Hospital (HFAR)-Lisbon, Azinhaga Dos Ulmeiros, Paço Do Lumiar, 1690-020 Lisbon, Portugal.
Anemia. 2020 Jul 29;2020:1048283. doi: 10.1155/2020/1048283. eCollection 2020.
Anemia and iron deficiency (ID) can impair quality of life and socioeconomic development. We evaluated the prevalence of anemia and ID in the adult Portuguese population in real-life contexts by gender, age, and pregnancy status. We performed a cross-sectional screening in adult individuals in mainland Portugal from 2013 to 2017. Participants completed a survey about demographics and signs or symptoms compatible with anemia, and ID and hemoglobin and ferritin concentrations were determined by point-of-care tests. We estimated and compared prevalence ratios (PR) of anemia and ID using Poisson regression with robust variance and the Wald chi-square test. We collected data from 11,030 individuals (26% men, 64% nonpregnant women, and 10% pregnant women). We found anemia in 51.8% (95% CI 50.1-53.4%) of nonpregnant women in fertile age, 46.6% (95% CI 44.7-48.6%) of nonpregnant women >51 years, 38.2% (95% CI 35.4-41.1%) of pregnant women, and 33.3% (95% CI 31.6-35.1%) of men. The prevalence of ID was 72.9% (95% CI 71.4-74.4%) in nonpregnant women in fertile age, 50.5% (95% CI 48.5-52.4%) in nonpregnant women >51 years, 94.8% (95% CI 93.3-96.0%) in pregnant women, and 28.9% (95% CI 27.3-30.6%) in men. We found significant associations between the prevalence of anemia or ID and nonpregnant women (PR: 1.50, 95% CI 1.42-1.59 or PR: 2.21, 95% CI 2.09-2.35, respectively), manifestation of signs or symptoms (PR: 1.19, 95% CI 1.53-1.23 or PR: 1.22, 95% CI 1.18-1.26), pregnant women (PR: 0.74, 95% CI 0.68-0.80 or PR: 1.30, 95% CI 1.27-1.33), and nonpregnant women ≤51 years (PR: 1.11, 95% CI 1.06-1.17 or PR: 1.42, 95% CI 1.36-1.48). In conclusion, anemia and ID represent moderate to severe public health problems, particularly among women in fertile age and in 3rd trimester, of pregnancy emphasizing the need to raise the public and health professionals' awareness of these problems and their prevention, diagnosis, and treatment.
贫血和缺铁会损害生活质量和社会经济发展。我们按性别、年龄和妊娠状态评估了葡萄牙成年人群体在现实生活中贫血和缺铁的患病率。2013年至2017年,我们在葡萄牙大陆的成年个体中进行了一项横断面筛查。参与者完成了一项关于人口统计学以及与贫血、缺铁相符的体征或症状的调查,并通过即时检验测定血红蛋白和铁蛋白浓度。我们使用稳健方差的泊松回归和Wald卡方检验估计并比较了贫血和缺铁的患病率比(PR)。我们收集了11,030名个体的数据(26%为男性,64%为非妊娠女性,10%为妊娠女性)。我们发现,育龄非妊娠女性中贫血患病率为51.8%(95%置信区间50.1 - 53.4%),51岁以上非妊娠女性中为46.6%(95%置信区间44.7 - 48.6%),妊娠女性中为38.2%(95%置信区间35.4 - 41.1%),男性中为33.3%(95%置信区间31.6 - 35.1%)。育龄非妊娠女性中铁缺乏患病率为72.9%(95%置信区间71.4 - 74.4%),51岁以上非妊娠女性中为50.5%(95%置信区间48.5 - 52.4%),妊娠女性中为94.8%(95%置信区间93.3 - 96.0%),男性中为28.9%(95%置信区间27.3 - 30.6%)。我们发现贫血或缺铁患病率与非妊娠女性(PR分别为:1.50,95%置信区间1.42 - 1.59或PR:2.21,95%置信区间2.09 - 2.35)、体征或症状表现(PR分别为:1.19,95%置信区间1.53 - 1.23或PR:1.22,95%置信区间1.18 - 1.26)、妊娠女性(PR分别为:0.74,95%置信区间0.68 - 0.80或PR:1.30,95%置信区间1.27 - 1.33)以及51岁及以下非妊娠女性(PR分别为:1.11,95%置信区间1.06 - 1.17或PR:1.42,95%置信区间1.36 - 1.48)之间存在显著关联。总之,贫血和缺铁是中度至重度的公共卫生问题,尤其是在育龄女性和妊娠晚期女性中,这凸显了提高公众和卫生专业人员对这些问题及其预防、诊断和治疗的认识的必要性。